Jessie Yeung | executive |
Ying Huang | executive |
Lori Macomber | executive |
Huidong Wang | analyst |
Jessica Fye | analyst |
Steven Gavel | executive |
Dingding Shi | analyst |
Ashwani Verma | analyst |
Leonid Timashev | analyst |
Jonathan Miller | analyst |
Guowei Fang | executive |
Yaron Werber | analyst |
James Shin | analyst |
Vikram Purohit | analyst |
Justin Zelin | analyst |
Mitchell Kapoor | analyst |
George Farmer | analyst |
Rick Bienkowski | analyst |
Sean McCutcheon | analyst |
Asthika Goonewardene | analyst |
Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to Jessie Yeung, Vice President of Investor Relations and Finance. Please go ahead.
Good morning.